Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery [NA]

View source ↗

Summary

This clinical trial is recruiting to compare the efficacy of three NSAID eye drops—bromfenac 0.09%, nepafenac 0.3%, and diclofenac 0.1%—in patients undergoing c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac ophthalmic solution 0.09% (bromfenac)
  • Diclofenac ophthalmic solution 0.1% (diclofenac)
  • Nepafenac ophthalmic solution 0.3% (nepafenac)

Snippet

Sponsor: Nemocnice Kolín | Conditions: Macular Oedema, Cataract Surgery | NA | Status: RECRUITING